Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: A phase III randomized study

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 270-275

  Gouvêa De Lima, Aline ^a   Villar, Rosângela Correa ^a   De Castro Jr , Gilberto ^b   Antequera, Reynaldo ^a   Gil, Erlon ^a   Rosalmeida, Mauro Cabral ^a   Federico, Miriam Hatsue Honda ^a   Snitcovsky, Igor Moisés Longo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto do Cancer do Estado de Sao Paulo   (Brazil)

Author keywords

Chemoradiotherapy; Head and neck cancer; Low level laser; Mucositis

Indexed keywords

CHEMORADIOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; CONCURRENT CISPLATIN; HEAD-AND-NECK CANCER; LOW LEVEL LASER; LOW LEVEL LASER THERAPY; MARGINAL BENEFIT; MUCOSITIS; ORAL CAVITY; ORAL MUCOSITIS; RADIATION DOSE; RADIATION FRACTIONS; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMAS;

ALUMINUM ARSENIDE; DISEASES; GALLIUM; GALLIUM ARSENIDE; PATIENT MONITORING; PLATINUM COMPOUNDS;

RADIOTHERAPY;

ALUMINUM; CARBOPLATIN; CISPLATIN; GALLIUM ARSENIDE; PACLITAXEL; PLACEBO;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; LARYNX CARCINOMA; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NECK METASTASIS; PAIN ASSESSMENT; PHARYNX CARCINOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; BODY WEIGHT; BRAZIL; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DEGLUTITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS, SEMICONDUCTOR; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; STOMATITIS; TREATMENT FAILURE; YOUNG ADULT;

EID: 83955165981     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.012     Document Type: Article

References (25)

1. A. Trotti, L.A. Bellm, and J.B. Epstein Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review Radiother Oncol 66 2003 253 262
2. L.S. Elting, D.M. Keefe, and S.T. Sonis Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation and impact on quality of life Cancer 113 2008 2704 2713
3. J.P. Pignon, A.L. Maître, and E. Maillard Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
4. H.V. Worthington, J.E. Clarkson, and O.B. Eden Interventions for preventing oral mucositis for patients with cancer receiving treatment Cochrane Database Syst Rev 2007 CD000978
5. R.J. Bensadoun, J.C. Franquin, and G. Ciais Low-energy He/Ne laser in the prevention of radiation-induced mucositis: A multicenter phase III randomized study in patients with head and neck cancer Support Care Cancer 7 1999 244 252
6. H. Arora, K.M. Pai, and A. Maiya Efficacy of He-Ne laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105 2008 180 186
7. M.T. Genot-Klastersky, J. Klastersky, and F. Awada The use of low-energy laser for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: Results of two prospective studies Support Care Cancer 16 2008 1381 1387
8. A. Barasch, D.E. Peterson, and J.M. Tanzer Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients Cancer 76 1995 2550 2556
9. D. Cowen, C. Tardieu, and M. Schubert Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplantation: Results of a double blind randomized trial Int J Radiat Oncol Biol Phys 38 1997 697 703
10. M.M. Schubert, F.P. Eduardo, and K.A. Guthrie A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation Support Care Cancer 15 2007 1145 1154
11. H.S. Antunes, A.M. Azevedo, and L.F.S. Bouzas Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: A randomized trial Blood 9 2007 2250 2255
12. E.B. Rubenstein, D.E. Peterson, and M.M. Schubert Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral gastrointestinal mucositis Cancer 100 2004 2026 2046
13. D.I. Rosenthal, and A. Trotti Strategies for managing radiation-induced mucositis in head and neck cancer Semin Radiat Oncol 19 2009 29 34
14. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
15. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
16. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
17. G. de Castro Jr., I.M. Snitcovsky, and E.M. Gebrim High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 264 2007 1475 1482
18. D.I. Rosenthal Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes J Support Oncol 5 9 Suppl. 4 2007 23 31
19. M.T. Genot, and J. Klastersky Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy Curr Opin Oncol 17 2005 236 240
20. G. Russo, R. Haddad, and M. Posner Radiation treatment breaks and ulcerative mucositis in head and neck cancer Oncologist 13 2008 886 898
21. H.J. Silver, M.S. Dietrich, and B.A. Murphy Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy Head Neck 29 2007 893 900
22. A. Xanthinaki, O. Nicolatou-Galitis, and P. Athanassiadou Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: Preliminary report Support Care Cancer 16 2008 1025-1033
23. World Association of Laser Therapy Consensus agreement on the design and conduct of clinical studies with low-level laser therapy and light therapy for musculoskeletal pain and disorders Photomed Laser Surg 24 2006 761 762
24. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results J Clin Oncol 28 2010 2732 2738
25. G. De Castro Jr., and R.S. Guindalini Supportive care in head and neck oncology Curr Opin Oncol 22 2010 221 225